Mahony Susan 4
4 · Axsome Therapeutics, Inc. · Filed Jun 9, 2026
Research Summary
AI-generated summary of this filing
Axsome (AXSM) Director Susan Mahony Receives RSU Award
What Happened
Susan Mahony, a director of Axsome Therapeutics (AXSM), received a grant of 1,721 restricted stock units (RSUs) on June 5, 2026. The Form 4 records the acquisition as a derivative award at $0.00 (typical for RSU grants, which are contingent rights to shares rather than open-market purchases).
Key Details
- Transaction date: 2026-06-05; Form 4 filed: 2026-06-09 (timely filing). Accession: 0001193125-26-264040.
- Transaction type/code: Award/Grant (A). Reported price: $0.00; reported value on Form 4: $0.
- Grant size: 1,721 RSUs. Each RSU converts to one share of common stock upon vesting (Footnote F1).
- Vesting: RSUs vest in full on the one-year anniversary of the grant (Footnote F2).
- Shares owned after transaction: Not specified in the summarized data provided.
Context
RSU grants are compensation awards that give the holder a contingent right to receive shares in the future; they do not represent an immediate cash purchase or sale. Because these awards typically vest over time, they are routine compensation and not a direct market signal like an open-market purchase or sale.
Insider Transaction Report
Form 4
Mahony Susan
Director
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-06-05+1,721→ 1,721 total→ Common Stock (1,721 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs vest in full on the one-year anniversary of the date of grant.
Signature
/s/ Nick Pizzie, Attorney-in-Fact|2026-06-09